Company Data
Cartesian Therapeutics Inc.
Ticker
RNAC
Current Price
$7.48 -1.58%
Market Cap
$194.5M
Price Target
Refer to Report
Volume
66.3K
52wk Range
$5.98 - $18.8
Overview
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.